Dossier
atopic dermatitis drug
Coverage of atopic dermatitis drug in the Nexus archive.
- AbbVie would gain an experimental eczema drug by buying biotech: report
AbbVie is reportedly attempting to acquire a biotech company developing a promising atopic dermatitis drug for $10.9 billion in cash, as per a Financial Times report.